We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Return of gut function was similar between those ...

Tranzyme Pharma Inc.'s drug ulimorelin failed to perform in a trial for bowel resection recovery acceleration, according to top-line results released Monday.

Rob Schuster, M.D., and colleagues at Santa Barbara Cottage Hospital, California, studied 34 patients who underwent sigmoid colon resection, in which surgeons remove a portion of the large intestine, ...

A recent study published in JAMA Surgery demonstrated the cost savings an enhanced recovery program can produce in colon cancer surgery, according to a Pain Medicine News report. The study examined ...